These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22897693)

  • 1. Breast and Prostate Cancer in a BRCA2 Carrier.
    Mahar T; Hicks DG
    Breast J; 2012 Sep; 18(5):511-3. PubMed ID: 22897693
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer.
    Singer CF; Rappaport-Fuerhauser C; Sopik V; Narod SA
    Clin Genet; 2015 Aug; 88(2):187-9. PubMed ID: 25112434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
    Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
    BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
    Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
    Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening-detected breast cancer in a man with BRCA2 mutation: case report.
    Brenner RJ; Weitzel JN; Hansen N; Boasberg P
    Radiology; 2004 Feb; 230(2):553-5. PubMed ID: 14752193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular breast cancer in men: case report and review of the literature.
    Mariolis-Sapsakos T; Theodoropoulos G; Flessas II; Orfanos F; Orfanos N; Konstantinou EA; Zagouri F; Vlachodimitropoulos D; Zografos GC
    Onkologie; 2010; 33(12):698-700. PubMed ID: 21124042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male breast cancer during treatment with leuprolide for prostate cancer.
    Yacoub J; Richardson C; Farmer M; Lee WR; Clark PE; Hurt G; Levine EA
    Clin Adv Hematol Oncol; 2007 Jul; 5(7):555-6; discussion 556-7. PubMed ID: 17679929
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
    Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
    Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
    Thorne H; Willems AJ; Niedermayr E; Hoh IM; Li J; Clouston D; Mitchell G; Fox S; Hopper JL; ; Bolton D
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1002-10. PubMed ID: 21733824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.
    Azzouzi AR; Stoppa-Lyonnet D; Roupret M; Larre S; Mangin P; Cussenot O
    Int J Urol; 2007 May; 14(5):445-6. PubMed ID: 17511731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.
    Sundararajan S; Ahmed A; Goodman OB
    Clin Adv Hematol Oncol; 2011 Oct; 9(10):748-55. PubMed ID: 22252577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four primary malignancies successively occurred in a BRCA2 mutation carrier: a case report.
    Fruscalzo A; Damante G; Calcagno A; Di Loreto C; Marchesoni D
    Cancer Invest; 2006 Oct; 24(6):611-4. PubMed ID: 16982466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.
    Haraldsson K; Loman N; Zhang QX; Johannsson O; Olsson H; Borg A
    Cancer Res; 1998 Apr; 58(7):1367-71. PubMed ID: 9537231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family.
    Diez O; Gutiérrez-Enríquez S; Masas M; Tenés A; Yagüe C; Arcusa A; Llort G
    Breast Cancer Res Treat; 2010 Sep; 123(2):587-90. PubMed ID: 20232139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male Breast Cancer: A Study in Small Steps.
    Korde LA
    Oncologist; 2015 Jun; 20(6):584-5. PubMed ID: 25986243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.
    Campos B; Díez O; Odefrey F; Domènech M; Moncoutier V; Martínez-Ferrandis JI; Osorio A; Balmaña J; Barroso A; Armengod ME; Benítez J; Alonso C; Stoppa-Lyonnet D; Goldgar D; Baiget M
    Hum Mutat; 2003 Apr; 21(4):452. PubMed ID: 12655574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.